Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)
- Conditions
- X-linked Myotubular Myopathy
- Interventions
- Other: History and physicalOther: Tidal breathingOther: Maximal respiratory pressuresOther: Peak cough flowOther: Pediatric Evaluation of Disability InventoryOther: PedsQL Multidimensional Fatigue ScaleOther: Review of ventilation requirements
- Registration Number
- NCT02453152
- Lead Sponsor
- University of Florida
- Brief Summary
This study is a longitudinal study evaluating the severity and progression of respiratory muscle function in patients with X-Linked Myotubular Myopathy (XLMTM) aged 0-14.
- Detailed Description
Subjects aged 0-7 will be evaluated every six months for a total of three evaluations (Baseline, Six-Month Visit, Twelve-Month Visit). Subjects aged 8-14 will be evaluated every twelve months for a total of two evaluations (Baseline, Twelve-Month Visit). Evaluations include medical history, physical exam, respiratory muscle tests, a qualitative interview related to the child's function and use of respiratory aids, and quality of life assessments.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 28
- Patients who have centronuclear myopathy resulting from an MTM1 genetic mutation.
- Patients who are between 0 and 14 years of age.
- Patients without a confirmed genetic mutation.
- Patients unable to travel to the site for the study.
- Patients participating in an interventional treatment study for XLMTM at the time of enrollment.
- Patients who are unable to complete study procedures.
- Patients who have a condition that, in the opinion of the investigator, would make participation in this study unsafe.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Males with X-linked myotubular myopathy Peak cough flow History and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements Males with X-linked myotubular myopathy PedsQL Multidimensional Fatigue Scale History and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements Males with X-linked myotubular myopathy Pediatric Evaluation of Disability Inventory History and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements Males with X-linked myotubular myopathy Review of ventilation requirements History and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements Males with X-linked myotubular myopathy History and physical History and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements Males with X-linked myotubular myopathy Tidal breathing History and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements Males with X-linked myotubular myopathy Maximal respiratory pressures History and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements
- Primary Outcome Measures
Name Time Method Change in baseline visit off-ventilator tolerance at 6 month visit and 12 month visit. Change in baseline visit, at 6 month visit and 12 month visit
- Secondary Outcome Measures
Name Time Method Change in baseline tidal breathing at 6 month visit and 12 month visit. Change in baseline visit, at 6 month visit and 12 month visit Subject's resting breathing pattern will be assessed.
Change in baseline peak cough flow at 6 month visit and 12 month visit. Change in baseline visit, at 6 month visit and 12 month visit Subjects will be assessed on the ability to generate a cough and the strength of that cough.
Change in baseline visit maximal respiratory pressures at 6 month visit, and 12 month visit. Change in baseline visit, at 6 month visit and 12 month visit Subject's maximal inspiratory and expiratory pressures.
Trial Locations
- Locations (1)
University of Florida
🇺🇸Gainesville, Florida, United States